Brief: Genscript Gets FDA Emergency Use Authorization For SARS-CoV-2 Neutralizing Antibody Detection Kit
09/11/2020 13:07
Nov 9 (Reuters) - Genscript Biotech Corp 1548.HK :
* GENSCRIPT RECEIVES FDA EMERGENCY USE AUTHORIZATION FOR
WORLD'S
FIRST SARS-COV-2 NEUTRALIZING ANTIBODY DETECTION KIT
Source text for Eikon: ID:nPn48tDTfa
Further company coverage: 1548.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale